Again, whether this is a process which is regulated is unknown, but it may help to explain why pharmacological use of DPP-4 inhibitors is generally not associated with weight loss (the appetite suppressive effects of increased intact GLP-1 levels being counter-balanced by the loss of the anorectic effects of PYY 3-36)
However, GLP-1 therapy offers a less invasive, lower-risk alternative with potentially similar results
exercise regularly
Eli Lilly retatrutide press release WEGOVY PRICE DROPS TO $349 PER MONTH November 2025 Effective November 17, 2025, Novo Nordisk has significantly reduced the price of its popular weight-loss drug, Wegovy
Inspired by lived experience, not perfection
People often think they've hit a plateau when the scale stops moving for a week, not realizing that their bodies process food at different rates